Press release
Hospital Acquired Infections Market Size, Share & Forecast USD 19.5 Bn by 2030 | Global Industry Analysis
Hospital Acquired Infections Market
The Hospital Acquired Infections Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At DataM Intelligence, we simplify complex market dynamics into actionable strategies-empowering businesses to remain competitive, scale confidently, and capitalize on the right opportunities in an ever-evolving landscape.
Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/hospital-acquired-infections-market?kb
Hospital Acquired Infections Market Overview
Hospital-acquired infections (HAIs), also known as nosocomial infections, are infections that patients develop during their stay in a healthcare facility, typically 48 hours or more after admission. These infections are not present or incubating at the time of admission and often result from exposure to bacteria, viruses, or fungi in clinical environments. Common types include urinary tract infections, surgical site infections, bloodstream infections, and pneumonia.
Research Methodology:
The global Hospital Acquired Infections Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.
Segment Covered in the Hospital Acquired Infections Market:
by Infection Type: Gastrointestinal Infections, Ventilator Associated Pneumonia, Urinary Tract Infections, Surgical Site Infections, Bloodstream Infections, Others
By End User: Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers, Others
By Drug Type: Antibacterial Drug, Antiviral Drug, Antifungal Drug, Others
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hospital-acquired-infections-market?kb
List of the Key Players in the Hospital Acquired Infections Market:
F Hoffmann-la Roche Ltd, Pfizer Inc., AbbVie Inc., AstraZeneca, GSK plc, Innoviva, ELI LILLY AND COMPANY, STERIS, Cipla Inc. and Basilea Pharmaceutica Ltd. among others.
Industry Development:
On May 23, 2023, the U.S. Food and Drug Administration (FDA) approved XACDURO a combination of durlobactam and sulbactam for injection-for intravenous use in adults aged 18 and older. This treatment is indicated for ventilator-associated bacterial pneumonia (VABP) and hospital-acquired bacterial pneumonia (HABP) caused by susceptible strains of the Acinetobacter baumannii-calcoaceticus complex. Innoviva Specialty Therapeutics aims to deliver advanced solutions for infectious diseases and critical care management.
Regional Analysis for Hospital Acquired Infections Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➠ What are the global sales, production, consumption, imports, and exports in the Hospital Acquired Infections market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Hospital Acquired Infections industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Hospital Acquired Infections market?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hospital Acquired Infections Market Size, Share & Forecast USD 19.5 Bn by 2030 | Global Industry Analysis here
News-ID: 4082787 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Hepatocellular Carcinoma Treatment Market Forecast: CAGR 7.4% to $1.96Mn by 2033 …
Hepatocellular Carcinoma Treatment Market size reached US$ 995.63 million in 2024 and is expected to reach US$ 1,964.88 million by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.
The Hepatocellular Carcinoma Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At…
Protein A Resin Market Poised for Growth Through 2031 | CAGR & Revenue Data - GE …
Global Protein A Resin market reached at a CAGR during the forecast period 2024-2031.
The Protein A Resin Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At DataM Intelligence, we simplify complex market dynamics into actionable strategies-empowering businesses to remain competitive, scale confidently, and…
Histology and Cytology Consumables Market | Driving Precision in Disease Diagnos …
Global Histology and Cytology Consumables Market is expected to reach growth with a Significant CAGR during the forecast period 2024-2031.
The Histology and Cytology Consumables Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including their innovative product offerings, competitive pricing strategies, financial performance metrics, strategic…
Global Polyamide Market To Reach New Heights USD 60.2Bn by 2031 | Key Drivers & …
The Global Polyamide Market reached USD 37.4 billion in 2022 and is expected to reach USD 60.2 billion by 2031, growing with a CAGR of 6.2% during the forecast period 2024-2031.
The Polyamide Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At DataM Intelligence,…
More Releases for Infection
Infection Prevention & Control Market 2026: Product Overview and Scope of Infect …
Infection Prevention & Control Market Research Report and Forecast to 2019-2026 Report provide an extensive research on the fast-evolving Infection Prevention & Control Market. It also gives competitive landscape of the leading companies with regional and Global analysis of the market till 2026.
The report mainly studies the size, recent trends and development status of the Infection Prevention & Control market, as well as investment opportunities, government policy, market dynamics (drivers,…
Human papillomavirus infection Treatment
Human Papillomavirus Infection Forecast 2019-2024
Drugs for Human Papillomavirus Infections Market Insights 2019, Global and Chinese Scenario is a professional and in depth study on the current state of the global Drugs for Human Papillomavirus Infections industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drugs for Human Papillomavirus Infections manufacturers and is a valuable source of guidance and direction for…
Infection Prevention and Control
Infection control products and accessories aids in the prevention and control of hospital associated & other healthcare infections. These products range from disinfectants to sterilization equipment used in the healthcare settings. Infections needs to be controlled while injecting the drugs, during the surgery and hospital stay of a patient. In addition, infection control and preventive measures aid to avoid the most common hospital infections among the healthcare staff.
Get Free 10…
Yeast Infection Market 2018 Global Industry Analysis By Site of infection (Vagin …
This Report Expects To Examine The Developments Of A Global Yeast Infection Market Including Its Market Improvement, Development Position Etc. Global Yeast Infection Market Research Report Will Help To Take Informed Decisions, Understand Opportunities, Plan Effective Business Strategies, Plan New Projects, Analyze Drivers And Restraints And Give Vision On The Forecast. Report Is A Specialist And Broad Research Report On The Major Regional Market Conditions, Concentrating On The United States, China,…
Gram-Negative Bacterial Infection Market - Infection-type Segmentation 2017 - 20 …
Global Gram-Negative Bacterial Infection Market: Snapshot
Worldwide, antimicrobial resistance is a soaring concern for a range of diseases, especially for enteric fever, respiratory tract infections, and various infections related with gram-negative bacilli (GNB). An upsurge in antibiotic resistance is mainly due to indiscriminate and inappropriate use of antibiotics and a marked decline in the development of efficacious antimicrobial agents. According to the Centers for Disease Control and Prevention (CDC), the…
Enteric Disease Testing Market (Amebiasis, C.difficile Infection, Campylobacteri …
"The Report Enteric Disease Testing Market (Amebiasis, C.difficile Infection, Campylobacteriosis, Cholera, Cryptosporidiosis, E.coli Infection, Giardiasis, H.pylori Infection, Norovirus Infection, Rotavirus Infection, Salmonellosis and Shigellosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Infectious enteric diseases are usually caused by a variety of bacteria, viruses and parasites when they enter…
